Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NOK vs GSK✓SelectedUSD · GSKNOK vs GSK performance historyLatest closeAs of-2.54%11/13
Stock and ETF performance explorer

NOK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+127.9%
GSK return
+105.0%
Excess return
+23.0%
Maximum drawdown
-62.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.5%+0.5%-3.1%-2.7%
7D+5.4%+1.1%+4.2%+5.0%
30D-14.1%+6.3%-20.5%-16.1%
3M-23.6%+1.8%-25.4%-24.7%
6M-45.1%+1.7%-46.8%-46.4%
YTD+24.7%+6.5%+18.2%+18.9%
1Y+19.0%+9.5%+9.5%+12.2%
3Y+147.0%+65.3%+81.7%+87.6%
5Y+58.2%+43.7%+14.4%+26.4%
All+127.9%+105.0%+23.0%+43.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling